How S&P 500 Giant Pfizer Is Tackling Hard-To-Treat Cancers
Yahoo Finance
Read Full Article at Yahoo Finance →Ad Slot — In-Article (728x90)
Pfizer said Sunday its Braftovi-tied regimen nearly doubled the length of time colon cancer patients lived without getting sicker.
This is a summary. For the full story, read the original article at Yahoo Finance.
Original source: Yahoo Finance